Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
 
Articles by Song Zhao
Total Records ( 1 ) for Song Zhao
  Chang-yan Xu , Song Zhao , Yi-yu Wang , Hui Sha , Jing-nan Sun , Feng-yan Jin and Feng Niu
  Background and Objective: The role of calcitonin on cancers complicated with bone metastasis has not been reported. This study aimed to evaluate the clinical efficacy of zoledronic acid combined with calcitonin for bone metastasis and osteoporosis in patients with lung cancer. Materials and Methods: Total of 100 patients with lung cancer complicated with bone metastasis and osteoporosis were randomly and equally divided into the control group (conventional analgesic (non-opioids → mild-opioids → strong opioids), calcium and 1,25-Dihydroxycholecalciferol) and the observational group (additional zoledronic acid combined with calcitonin therapy). Then, the life quality, bone pain, activity ability, metastatic lesion, serum biochemical indicators of bone metabolism and bone mineral density (BMD) of hip joint, as well as the adverse reactions and skeletal-related events (SREs) were recorded in both two groups. The effectiveness of treatment as ordered categorical variable was measured using Mann-Whitney U method. All the data of serum indicators were expressed as the mean±SD and analyzed using paired t-test for the comparison before and after treatment. Independent samples t-test was used for the comparison between the two groups. Chi-square test was used for the comparison of incidence of adverse reactions and SREs. Results: The significant improvement of life quality, bone pain, activity ability, serum biochemical indicators of bone metabolism and BMD of hip joint were observed in the observational group compared with the control group (p<0.01). Bone metastatic lesions were significantly reduced by this combined therapy compared with conventional therapy (p<0.05). The incidences of adverse reactions and SREs in the observational group were significantly lower than that in the control group (6.0 vs. 24.0% and 4.0 vs. 22.0%, p<0.05), respectively. Conclusion: The application of zoledronic acid combined with calcitonin was significantly more effective for bone metastasis and osteoporosis in patients with lung cancer, compared with conventional therapy.
 
 
 
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility